BHP Group (ASX:BHP) Rises 2% on Friday on Record FY25 Copper and Iron Ore Production

Shares ofBHP Group Limited (ASX: BHP)rose nearly 2% to AUD 39.93 on Friday morning following the release of its fourth quarter and full-year operational review for the 2025 financial year. The update showed increased output across key commodities, leading to record production levels in …

Team Kalkine | 18 Jul 2025| Read Time : 10 Mins

Bannerman Energy Gains ‘Buy’ Rating with 57% Upside Potential, Here's Why

Buy ratings sustained by 2 analysts; consensus price target of AUD 4.28 implies a 48.10% upside.

Sonal Goyal | 18 Jul 2025| Read Time : 10 Mins

Life360 (ASX: 360) and Megaport (ASX:MP1) Lift AXIJ to New Record

Australia’s technology sector climbed to new heights on Thursday, with the S&P/ASX All Technology Index (.AXIJ) rising as much as 1.5% during the session to set a fresh record. The sector rally followed overnight gains on Wall Street, where U.S. stocks hit all-time highs, …

Team Kalkine | 18 Jul 2025| Read Time : 10 Mins

EVZ (ASX:EVZ) Forecasts FY25 Revenue Between AUD 108M and AUD 110M

EVZ Limited (ASX:EVZ),an Australian company providing engineering and technical services to the energy, resources, and construction sectors, has issued guidance for its financial results for the full year ended 30 June 2025. According to the preliminary and unaudited figures, the company expects revenue in …

Team Kalkine | 18 Jul 2025| Read Time : 10 Mins

Macquarie Maintains 'Outperform' Rating on AGL Energy

Macquarie rates AGL ‘Outperform’ with a target price of AUD 11.13, indicating a potential upside of 16.30%.

Sonal Goyal | 18 Jul 2025| Read Time : 10 Mins

Mesoblast (ASXMSB) Reports AUD 13.2M in Ryoncil® Revenue in First Post-Launch Quarter, Shares Up

Mesoblast Limited (Nasdaq: MESO; ASX: MSB), an Australian-headquartered company developing allogeneic cellular medicines for inflammatory diseases, has reported unaudited gross revenue of AUD 13.2 million from sales of its FDA-approved product Ryoncil® (remestemcel-L-rknd) in the United States for the quarter ended 30 June 2025. …

Team Kalkine | 18 Jul 2025| Read Time : 10 Mins

CAR Group (ASX:CAR) Unveils FY25 Estimates, Attracts Positive Analysts Rating

Proforma EBITDA is forecasted to rise 11–12%, while adjusted NPAT is seen increasing by the same range.

Sonal Goyal | 17 Jul 2025| Read Time : 10 Mins

News

BHP Group (ASX:BHP) Rises 2% on Friday on Record FY25 Copper and Iron Ore Production

Bannerman Energy Gains ‘Buy’ Rating with 57% Upside Potential, Here's Why

Life360 (ASX: 360) and Megaport (ASX:MP1) Lift AXIJ to New Record

EVZ (ASX:EVZ) Forecasts FY25 Revenue Between AUD 108M and AUD 110M

Macquarie Maintains 'Outperform' Rating on AGL Energy

Mesoblast (ASXMSB) Reports AUD 13.2M in Ryoncil® Revenue in First Post-Launch Quarter, Shares Up

CAR Group (ASX:CAR) Unveils FY25 Estimates, Attracts Positive Analysts Rating

Premium News

Alliance Aviation (ASX:AQZ) Reports 11% H1FY25 Revenue Growth, Maintains FY25 Guidance

Is the Global Defense Boom Fuelling Investments in Aerospace and Defense ETFs?

Telix Pharmaceuticals (ASX:TLX) Targets AUD 1.18–1.23Bn Revenue, Plans to Launch Three Products in FY25

U.S. Aerospace and Defense ETFs Rise on Sector Tailwinds and Diverse Index Strategies

Cleanaway (ASX:CWY) Gains ACCC Approval, Guides for Double-Digit EBIT Growth in FY25

Amplia Therapeutics (ASX:ATX) Share Price Up 442% in a Month, Despite AUD 6.57Mn Losses in FY25

Eureka Group (ASX:EGH) Targets Asset Divestments and Acquisitions to Drive FY25 Growth